Role of insulin resistance in kidney dysfunction: insights into the mechanism and epidemiological evidence.
about
Beat it early: putative renoprotective haemodynamic effects of oral hypoglycaemic agentsLowering cholesterol in chronic kidney disease: is it safe and effective?Metabolic syndrome, serum uric acid and renal risk in patients with T2D.Normoglycemic diabetic nephropathy: the role of insulin resistance.Insulin resistance in chronic kidney disease: a step closer to effective evaluation and treatment.Association of insulin resistance with chronic kidney disease in non-diabetic subjects with normal weight.Association between the ENPP1 K121Q polymorphism and risk of diabetic kidney disease: a systematic review and meta-analysisSerum resistin and glomerular filtration rate in patients with type 2 diabetes.Obesity and renovascular disease.Discordant associations of lipid parameters with albuminuria and chronic kidney disease: a population-based study.Testosterone and gonadotropins but not SHBG vary with CKD stages in young and middle aged men.Evidence of a causal relationship between high serum adiponectin levels and increased cardiovascular mortality rate in patients with type 2 diabetesRelationship Between Sarcopenia and Albuminuria: The 2011 Korea National Health and Nutrition Examination Survey.Predictors of chronic kidney disease in type 2 diabetes: A longitudinal study from the AMD Annals initiative.Proteomic and phosphoproteomic analysis of renal cortex in a salt-load rat model of advanced kidney damage.Clinical correlates of insulin sensitivity and its association with mortality among men with CKD stages 3 and 4.Serum ZAG Levels Were Associated with eGFR Mild Decrease in T2DM Patients with Diabetic Nephropathy.Higher glomerular filtration rate is related to insulin resistance but not to obesity in a predominantly obese non-diabetic cohort.The kidney in obesity.Effects of Low Muscle Mass on Albuminuria and Chronic Kidney Disease in Patients With Type 2 Diabetes: The Korean Sarcopenic Obesity Study (KSOS).The impact of insulin resistance on the kidney and vasculature.The metabolic syndrome and chronic kidney disease.Epidemiology of diabetic kidney disease in adult patients with type 1 diabetes in Italy: The AMD-Annals initiative.Effect of Selenium Supplementation on Glycemic Control and Lipid Profiles in Patients with Diabetic Nephropathy.Increased risk of glomerular hyperfiltration in subjects with impaired glucose tolerance and newly diagnosed diabetes.Mast Cell and M1 Macrophage Infiltration and Local Pro-Inflammatory Factors Were Attenuated with Incretin-Based Therapies in Obesity-Related Glomerulopathy.Microalbuminuria as a simple predictor of incident diabetes over 8 years in the Korean Genome and Epidemiology Study (KoGES).Disparate phospho-Smad2 levels in advanced type 2 diabetes patients with diabetic nephropathy and early experimental db/db mouse model.Obesity-related glomerulopathy: pathogenesis, pathologic, clinical characteristics and treatment.Maternal exposure to high-fat and high-fructose diet evokes hypoadiponectinemia and kidney injury in rat offspring.Dissecting PUGNAc-mediated inhibition of the pro-survival action of insulin.The magnitude of obesity and metabolic syndrome among diabetic chronic kidney disease population: A nationwide study.Impact of Diabetes Mellitus on the Risk of End-Stage Renal Disease in Patients with Systemic Lupus Erythematosus.Editorial: treating the liver to treat the kidney in non-alcoholic steatohepatitis - authors' reply.Chronic kidney disease
P2860
Q27010669-B7376155-94A7-4C86-9384-2C3DA0C0168FQ28083502-E8CBF902-4EB6-475A-BC99-3A385F240A88Q33579624-51D3E734-1284-4B74-A864-91F289B80979Q33935871-673D26B1-C16A-48CF-81AB-6F7AB1DF2C6AQ33992726-90295FD6-976D-4633-AFFE-75BA602EBE9AQ34994505-A61CE742-CEA3-4D42-9CB2-69729B69DD33Q35201598-1E506245-3594-42DB-A658-3C2D7A25157BQ35219743-7A99F00F-7B03-41EC-9EFA-7854D30A4BB2Q35958492-3AB79E77-623C-41F5-9B6E-4C806040424CQ36321501-0873DBA7-372B-4197-A4E4-3407752CB141Q36344135-E360781A-8161-4142-AEF5-C600A439EF01Q36513591-7580C58C-E88A-456F-A7C6-7280217E613EQ37204931-CA9E7623-AC79-48A1-83F8-C0A59AC5F4B1Q37327922-4208FAC6-C544-4551-92E1-D315854B43A5Q37360338-35818E45-20DC-407B-988C-CAA7DFA32DB7Q37682226-A09D8D33-4082-4D87-A643-46079AD22502Q37703608-9460B39E-466C-4017-AE34-EDC1E5A53016Q37734623-11F5EC81-6462-45EF-B895-CC175817F497Q38429861-7A491D3F-A4DF-4541-92DB-062F24E1C225Q38838334-4E466BEB-B6E6-4E93-8AEA-170B2DE81A58Q38982413-CB3C709D-08EC-42CC-B38F-B78188E95407Q39056509-C490330D-819D-48ED-BFA2-B892F5FB159DQ39115570-993D5936-2ACF-4212-AE32-BEB4D19F4DC6Q40189595-A0D486D5-549D-43AE-9074-6B367F7A6123Q41094401-83EA4CE8-D770-4CF6-B547-D82C063E7410Q41557819-1AA10587-CFF3-44BD-8A22-37148A68CE0FQ44911008-AE5CA23B-5742-4A1A-AF82-A16574A6FD74Q47956890-5DD3626F-1768-45B5-8E2B-A9234C6A2CEBQ48698019-7438268F-77EF-4EFD-B3B1-A57166C4B1A3Q50898300-FC8945E3-82DB-42A7-9B6A-1AA689C7D005Q53144959-63E30F68-1F3C-40A3-8B16-017533964C6AQ53685411-FAE1C65A-87A8-4DA5-9147-3737E868BDFAQ53694839-3D13911D-BA8A-477B-86D4-3054B7D48047Q54724806-C5DDBF7A-450A-44AF-ADBF-64720C5EEB81Q57701181-E0396206-5D92-45B2-B649-3E63BD87D41A
P2860
Role of insulin resistance in kidney dysfunction: insights into the mechanism and epidemiological evidence.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Role of insulin resistance in ...... and epidemiological evidence.
@en
type
label
Role of insulin resistance in ...... and epidemiological evidence.
@en
prefLabel
Role of insulin resistance in ...... and epidemiological evidence.
@en
P2860
P50
P356
P1476
Role of insulin resistance in ...... m and epidemiological evidence
@en
P2093
S De Cosmo
V Trischitta
P2860
P356
10.1093/NDT/GFS290
P407
P577
2012-10-09T00:00:00Z